GW&K Investment Management LLC Has $34.99 Million Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

GW&K Investment Management LLC grew its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 1.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,730,356 shares of the real estate investment trust's stock after buying an additional 25,193 shares during the period. GW&K Investment Management LLC owned approximately 0.25% of Healthpeak Properties worth $34,988,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Norges Bank acquired a new position in shares of Healthpeak Properties in the 4th quarter valued at $166,804,000. Resolution Capital Ltd bought a new stake in shares of Healthpeak Properties during the 4th quarter valued at about $122,795,000. Long Pond Capital LP bought a new position in shares of Healthpeak Properties during the 4th quarter worth about $86,885,000. Northern Trust Corp boosted its position in shares of Healthpeak Properties by 32.6% during the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after purchasing an additional 2,590,530 shares in the last quarter. Finally, National Bank of Canada FI boosted its position in shares of Healthpeak Properties by 56,120.9% during the 4th quarter. National Bank of Canada FI now owns 1,686,065 shares of the real estate investment trust's stock worth $34,181,000 after purchasing an additional 1,683,066 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Trading Down 6.8%

Healthpeak Properties stock traded down $1.28 during midday trading on Friday, hitting $17.60. 8,008,113 shares of the stock were exchanged, compared to its average volume of 5,721,218. Healthpeak Properties, Inc. has a fifty-two week low of $16.64 and a fifty-two week high of $23.26. The stock has a market capitalization of $12.22 billion, a price-to-earnings ratio of 43.99, a PEG ratio of 2.17 and a beta of 1.03. The stock's 50-day simple moving average is $17.69 and its 200 day simple moving average is $18.86. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The business had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same quarter last year, the firm posted $0.45 earnings per share. The business's revenue for the quarter was down .2% compared to the same quarter last year. On average, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Friday, September 19th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, September 19th. This represents a $1.22 annualized dividend and a dividend yield of 6.93%. Healthpeak Properties's payout ratio is currently 305.00%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DOC. Robert W. Baird dropped their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Scotiabank decreased their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research report on Monday, May 12th. Argus restated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Wells Fargo & Company decreased their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, June 2nd. Finally, Wedbush reduced their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $23.27.

Insiders Place Their Bets

In other Healthpeak Properties news, Director Tommy G. Thompson acquired 5,777 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The shares were acquired at an average cost of $17.27 per share, for a total transaction of $99,768.79. Following the transaction, the director directly owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This represents a 4.17% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director John T. Thomas bought 4,200 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director directly owned 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 29,764 shares of company stock worth $521,909. Corporate insiders own 0.23% of the company's stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.